Log In
Print
BCIQ
Print
Print this Print this
 

AZD0837

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionThrombin inhibitor
Molecular Target Thrombin (Factor IIa) (F2)
Mechanism of ActionThrombin inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationThrombosis
Indication DetailsTreat thrombosis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today